However, in renal cancer and chronic lymphoblastic leukemia, the expression of CacyBP/SIP is decreased (Sun et al., 2007; Fu et al., 2016), which plays a role in tumor inhibition. The gene discussed is CACYBP; the disease is renal carcinoma.